Portfolio Prior to 2008
Vernalis is a development-stage pharmaceutical company listed on the London Stock Exchange.
OMRIX biopharmaceuticals is a marketing stage biotechnology company that develops and markets a unique surgical sealant, as well as a suite of immunology and hemophilia products. The company was initially listed on NASDAQ and subsequently acquired by J&J.
Intercell is a biotechnology company focused on the development of vaccines against infectious diseases and cancer, initially listed on the Vienna Stock Exchange, and subsequently merged into Valneva.
Ingenium Pharmaceuticals is a drug discovery and development company focused on generating the biological information critical to the development of therapeutics, specifically in the area of pain management and inflammatory disease. The company was acquired by ProBiodrug AG.
Galapagos is a biotechnology company focused on the identification of disease modifying drug targets and the subsequent development of breakthrough medicine based on these targets. The company is listed on Euronext.
EpiCept Corporation is a specialty niche pharmaceutical company. Epicept’s objective is to address unmet medical needs in cancer and pain management. The company is listed on the OTCQX and Stockholm Stock Exchange.
Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best-in-class small molecule drugs in the anti-infectives field. The company is listed on the NASDAQ.
DrugAbuse Sciences was a specialty pharmaceutical company dedicated to improving the treatment of alcohol and substance abuse and dependence. The company assets have been acquired by Elbion (now part of Biotie).
DeveloGen is a biology driven specialty pharmaceutical company focusing on the development of treatments for metabolic disorders, such as diabetes, obesity and metabolic syndrome. The company was acquired by Evotec.
Curacyte is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. The company was acquired by Wilex.
Coley Pharmaceutical Group discovers, develops and commercializes a new class of drugs that stimulate the human immune system to treat and prevent cancer, asthma, allergy and infectious diseases. The company was initially listed on NASDAQ and subsequently acquired by Pfizer.
Breonics, Inc. is a biomedical research and development company on the cutting edge of innovative medical products for the clinical organ transplant and tissue replacement markets.
BioXell was a research and development biopharmaceutical company with globally recognised leadership in Vitamin D and its in-depth understanding of the molecular basis of inflammation. The company was initially listed on the Swiss stock exchange and subsequently acquired by Cosmo Pharmaceuticals.
Avantium is a Dutch service and R&D company. Avantium provides innovative high-throughput R&D services and technologies to the pharmaceutical, chemical and energy industries. Our position was sold in a secondary transaction.